Consumer Groups Recommend Increased Enforcement Against Pharmaceutical Rebate Walls
On February 18, 2021, Consumer Action and U.S. Public Interest Research Group submitted recommendations to the Biden/Harris Transition team that the Federal Trade Commission increase its enforcement efforts to prohibit anticompetitive pharmaceutical rebate walls. In the memorandum submitted to the Biden/Harris Transition Team, Consumer Action and U.S. Public Interest Research Group explain that pharmaceutical rebate walls are exclusionary contacting practices that a drug manu
